NCT02481570

Brief Summary

The standard anesthetic care plan for people having adolescent idiopathic scoliosis surgery will be accompanied by a pharmacokinetic simulation of the administered drugs to suggest opportunities to adjust drug doses to achieve tolerable pain control after surgery, avoid respiratory depression and allow patients to respond quickly either during intraoperative testing or at the conclusion of surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 25, 2015

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2016

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2017

Completed
Last Updated

August 12, 2019

Status Verified

August 1, 2019

Enrollment Period

1.1 years

First QC Date

June 23, 2015

Last Update Submit

August 9, 2019

Conditions

Keywords

Adolescent Idiopathic ScoliosisScoliosis surgeryPharmacokinetic simulation

Outcome Measures

Primary Outcomes (2)

  • 4-Item Pain Intensity Measure

    0 - 10 (0=no pain; 10 = pain as bad as can be)

    24 hours

  • Respiratory depression

    Respiratory rate less than 10 breaths per minute (bpm), or administration of naloxone.

    24 hours

Secondary Outcomes (1)

  • Utility of pharmacokinetic simulation

    4 - 8 hours (Intraoperative period)

Study Arms (1)

Anesthesia optimization

EXPERIMENTAL

Information from the pharmacokinetic simulation during an anesthetic regimen of a propofol based Total Intravenous Anesthetic (TIVA)

Other: pharmacokinetic simulation

Interventions

The aim of the simulation is to recommend dosing adjustments to improve postoperative analgesia with a rapid emergence.

Anesthesia optimization

Eligibility Criteria

Age10 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) class 1-2
  • At least 10 years of age and not older than 18 years of age
  • Diagnosis of idiopathic adolescent scoliosis

You may not qualify if:

  • Currently pregnant
  • Currently breastfeeding
  • Currently being treated with opiates
  • Currently being treated with alpha2 agonists
  • Currently being treated with anticonvulsants
  • Currently being treated with antidepressants
  • History of significant restrictive lung disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UF Health

Gainesville, Florida, 32610-3003, United States

Location

Related Publications (1)

  • Tams C, Dooley FC, Sangari TS, Gonzalez-Rodriguez SN, Stoker RE, Phillips SA, Koenig M, Wishin JM, Molinari SC, Blakemore LC, Seubert CN. Methadone and a Clinical Pathway in Adolescent Idiopathic Scoliosis Surgery: A Historically Controlled Study. Global Spine J. 2020 Oct;10(7):837-843. doi: 10.1177/2192568219878135. Epub 2019 Sep 26.

MeSH Terms

Conditions

Respiratory InsufficiencyPain, Postoperative

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Christoph Seubert, MD PhD DABNM

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2015

First Posted

June 25, 2015

Study Start

November 1, 2015

Primary Completion

November 21, 2016

Study Completion

August 15, 2017

Last Updated

August 12, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations